Related Experiment Video
Updated: Jun 24, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
A Lateral-Flow Device for the Rapid Detection of Scedosporium Species
Genna E Davies1, Christopher R Thornton1,2
1ISCA Diagnostics Ltd., B12A, Hatherly Laboratories, Prince of Wales Road, Exeter EX4 4PS, UK.
Abstract:
Scedosporium species are human pathogenic fungi, responsible for chronic, localised, and life-threatening disseminated infections in both immunocompetent and immunocompromised individuals. The diagnosis of Scedosporium infections currently relies on non-specific CT, lengthy and insensitive culture from invasive biopsy, and the time-consuming histopathology of tissue samples. At present, there are no rapid antigen tests that detect Scedosporium-specific biomarkers. Here, we report the development of a rapid (30 min) and sensitive (pmol/L sensitivity) lateral-flow device (LFD) test, incorporating a Scedosporium-specific IgG1 monoclonal antibody (mAb), HG12, which binds to extracellular polysaccharide (EPS) antigens between ~15 kDa and 250 kDa secreted during the hyphal growth of the pathogens. The test is compatible with human serum and allows for the detection of the Scedosporium species most frequently reported as agents of human disease (Scedosporium apiospermum, Scedosporium aurantiacum, and Scedosporium boydii), with limits of detection (LODs) of the EPS biomarkers in human serum of ~0.81 ng/mL (S. apiospermum), ~0.94 ng/mL (S. aurantiacum), and ~1.95 ng/mL (S. boydii). The Scedosporium-specific LFD (ScedLFD) test therefore provides a potential novel opportunity for the detection of infections caused by different Scedosporium species.
Insights
A new rapid lateral-flow device (LFD) test detects Scedosporium fungal infections in 30 minutes. This sensitive test uses a monoclonal antibody to identify Scedosporium-specific biomarkers in human serum, aiding in faster diagnosis.
Area of Science:
- Medical Mycology
- Diagnostic Microbiology
- Immunodiagnostics
Background:
- Scedosporium species are significant human pathogens causing diverse infections.
- Current diagnostic methods for Scedosporium infections are slow and invasive.
- There is a critical need for rapid and sensitive diagnostic tools for Scedosporium.
Purpose of the Study:
- To develop a rapid and sensitive diagnostic test for Scedosporium infections.
- To detect Scedosporium-specific biomarkers in human serum.
Main Methods:
- Development of a lateral-flow device (LFD) test utilizing a Scedosporium-specific IgG1 monoclonal antibody (mAb), HG12.
- The LFD targets extracellular polysaccharide (EPS) antigens secreted by Scedosporium hyphae.
- Testing compatibility with human serum and determining limits of detection (LODs) for key Scedosporium species.
Main Results:
- The developed Scedosporium-specific LFD (ScedLFD) test provides results in 30 minutes with pmoL/L sensitivity.
- The test accurately detects EPS biomarkers from S. apiospermum, S. aurantiacum, and S. boydii in human serum.
- Achieved LODs were approximately 0.81 ng/mL for S. apiospermum, 0.94 ng/mL for S. aurantiacum, and 1.95 ng/mL for S. boydii.
Conclusions:
- The ScedLFD test offers a novel, rapid, and sensitive method for detecting Scedosporium infections.
- This diagnostic tool has the potential to significantly improve the management of Scedosporium-related diseases.
- The test enables the detection of multiple Scedosporium species responsible for human infections.
More Related Videos
Related Concept Videos
Microbial Biosensors
Rapid Identification of Pathogens

